{
  "_source_id": 58,
  "sources": {
    "Mejores Prácticas UX para Aplicaciones Médicas": {
      "https://topflightapps.com/ideas/healthcare-mobile-app-design/": {
        "id": 1,
        "publisher": "TopFlight Apps",
        "url": "https://topflightapps.com/ideas/healthcare-mobile-app-design/",
        "title": "Health App Design: Improving UI/UX in Medical Apps with Examples",
        "info": "Información detallada sobre diseño visual, colores, tipografía, iconografía y tendencias de diseño para aplicaciones médicas dirigidas a pacientes, incluyendo ejemplos de aplicaciones exitosas"
      },
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC6785326/": {
        "id": 2,
        "publisher": "PubMed Central",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6785326/",
        "title": "A Systematic Review of Patient-Facing Visualizations of Personal Health Data",
        "info": "Revisión sistemática de 39 estudios sobre visualización de datos médicos dirigidos a pacientes, identificando tipos de gráficos más efectivos, códigos de color y mejores prácticas de presentación"
      },
      "https://www.eleken.co/blog-posts/user-interface-design-for-healthcare-applications": {
        "id": 3,
        "publisher": "Eleken",
        "url": "https://www.eleken.co/blog-posts/user-interface-design-for-healthcare-applications",
        "title": "Healthcare UI Design 2025: Best Practices + Examples",
        "info": "Guía completa de mejores prácticas UX/UI para aplicaciones de salud, tendencias 2025, diseño centrado en roles, IA para diagnósticos y paneles predictivos"
      },
      "https://uxplanet.org/designing-medical-data-dashboards-ux-patterns-benchmarking-f83426ed6c07": {
        "id": 4,
        "publisher": "UX Planet",
        "url": "https://uxplanet.org/designing-medical-data-dashboards-ux-patterns-benchmarking-f83426ed6c07",
        "title": "Designing Medical Data Dashboards: UX patterns & Benchmarking",
        "info": "Análisis detallado de patrones de UX para dashboards médicos, benchmarking de 8 plataformas médicas existentes, identificación de desafíos comunes y características esenciales"
      },
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC9741729/": {
        "id": 5,
        "publisher": "PubMed Central",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9741729/",
        "title": "Visualization Techniques in Healthcare Applications: A Narrative Review",
        "info": "Revisión narrativa sobre técnicas de visualización en aplicaciones de salud, incluyendo tipos de dashboards, ventajas para la toma de decisiones clínicas y casos de estudio históricos"
      },
      "https://www.ada.gov/resources/2024-03-08-web-rule/": {
        "id": 6,
        "publisher": "U.S. Department of Justice",
        "url": "https://www.ada.gov/resources/2024-03-08-web-rule/",
        "title": "Fact Sheet: New Rule on the Accessibility of Web Content and Mobile Apps",
        "info": "Nuevas regulaciones ADA 2024 para accesibilidad web y aplicaciones móviles, requisitos de cumplimiento WCAG 2.1 AA y fechas de cumplimiento para entidades médicas"
      },
      "https://logicloom.in/patient-centric-dashboards-that-actually-empower-people-how-to-design-healthcare-interfaces-that-inform-engage-and-truly-support-long-term-wellness/": {
        "id": 7,
        "publisher": "LogicLoom",
        "url": "https://logicloom.in/patient-centric-dashboards-that-actually-empower-people-how-to-design-healthcare-interfaces-that-inform-engage-and-truly-support-long-term-wellness/",
        "title": "Patient-Centric Dashboards That Empower and Engage Users",
        "info": "Mejores prácticas para diseñar dashboards centrados en pacientes, involucrando a pacientes en el diseño, personalización, gamificación y diseño para seguimiento continuo"
      },
      "https://moldstud.com/articles/p-transforming-patient-data-successful-case-studies-in-healthcare-visualization": {
        "id": 8,
        "publisher": "MoldStud",
        "url": "https://moldstud.com/articles/p-transforming-patient-data-successful-case-studies-in-healthcare-visualization",
        "title": "Transforming Patient Data with Successful Healthcare Visuals",
        "info": "Casos de estudio exitosos de visualización de datos médicos con estadísticas de impacto, incluyendo paneles interactivos, GIS, machine learning y aplicaciones móviles"
      }
    },
    "Análisis Completo del Código HIA": {
      "https://github.com/harshhh28/hia.git": {
        "id": 9,
        "publisher": "Harsh Gajjar (harshhh28)",
        "url": "https://github.com/harshhh28/hia.git",
        "title": "HIA - Health Insights Agent",
        "info": "Repositorio oficial del sistema HIA (Health Insights Agent) - Agente de IA para análisis de reportes médicos con arquitectura basada en agentes, procesamiento de PDFs, integración con Groq y Supabase para análisis de sangre"
      }
    },
    "Rangos de Medicina Funcional para Perfil Lipídico": {
      "https://www.ifm.org/articles/advanced-lipid-testing-cardio-health": {
        "id": 10,
        "publisher": "Institute for Functional Medicine",
        "url": "https://www.ifm.org/articles/advanced-lipid-testing-cardio-health",
        "title": "Advanced Lipid Testing: A Deeper Insight to Cardiometabolic Health",
        "info": "Biomarcadores de medicina funcional incluyendo ApoB, LDL-P, Lp(a), tamaño de partículas LDL/HDL, y enfoque en pruebas avanzadas para mejor comprensión del riesgo cardiometabólico."
      },
      "https://drhyman.com/blogs/content/podcast-ep856": {
        "id": 11,
        "publisher": "Dr. Mark Hyman",
        "url": "https://drhyman.com/blogs/content/podcast-ep856",
        "title": "Why LDL is Not Enough: The Tests Your Doctor is Missing",
        "info": "Rangos óptimos de medicina funcional: HDL >60 mg/dL, LDL <70 mg/dL, ApoB 40-70 mg/dL, triglicéridos <70 mg/dL, triglicéridos/HDL ratio 1:1. Comparación con medicina convencional."
      },
      "https://www.medichecks.com/blogs/longevity/what-are-apolipoproteins-a1-and-b?srsltid=AfmBOorc2LNeoV4OWLFURme6rhz3XkmaavQO9R0JfiNCX_id-vrLvVG7": {
        "id": 12,
        "publisher": "Medichecks",
        "url": "https://www.medichecks.com/blogs/longevity/what-are-apolipoproteins-a1-and-b?srsltid=AfmBOorc2LNeoV4OWLFURme6rhz3XkmaavQO9R0JfiNCX_id-vrLvVG7",
        "title": "What are apolipoproteins A1 and B?",
        "info": "Información sobre apolipoproteínas A1 y B, ratio ApoB/ApoA1 como medida superior del riesgo cardiovascular, y factores que influyen en sus niveles."
      },
      "https://elevatebotanica.com/blogs/blog/trigliceridos-y-colesterol-vision-desde-la-medicina-funcional": {
        "id": 13,
        "publisher": "Elevate Botanica",
        "url": "https://elevatebotanica.com/blogs/blog/trigliceridos-y-colesterol-vision-desde-la-medicina-funcional",
        "title": "Triglicéridos y colesterol: visión desde la medicina funcional",
        "info": "Rangos clínicos de medicina funcional: triglicéridos <150 mg/dL, LDL <100 mg/dL, HDL >40 mg/dL (hombres) y >50 mg/dL (mujeres), enfoque integral de medicina funcional."
      },
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC9025822/": {
        "id": 14,
        "publisher": "PMC/NIH",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9025822/",
        "title": "Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence",
        "info": "Límites de riesgo para LDL pequeñas y densas: >50 mg/dL predice riesgo en ARIC, >46 mg/dL aumenta riesgo CVD en MESA, >35 mg/dL riesgo en CHD estable. Correlación con triglicéridos."
      },
      "https://www.jacc.org/doi/10.1016/j.jacc.2025.04.024": {
        "id": 15,
        "publisher": "Journal of the American College of Cardiology",
        "url": "https://www.jacc.org/doi/10.1016/j.jacc.2025.04.024",
        "title": "Maturation of Lipid Management in the 2025 ACC/AHA Acute Coronary Syndrome Guideline",
        "info": "Nuevas guías ACC/AHA 2025: objetivo LDL-C 55-69 mg/dL para intensificación terapéutica, recomendación de evaluar ApoB, non-HDL-C y Lp(a) para refinamiento del riesgo."
      },
      "https://www.atherosclerosis-journal.com/article/S0021-9150(25)01377-2/fulltext": {
        "id": 16,
        "publisher": "Atherosclerosis Journal",
        "url": "https://www.atherosclerosis-journal.com/article/S0021-9150(25)01377-2/fulltext",
        "title": "2025 Focused Update of the 2019 ESC/EAS Guidelines for Dyslipidaemias",
        "info": "Guías ESC 2025: objetivo principal reducir LDL-C, Lp(a) >50 mg/dL como modificador de riesgo, icosapentil etilo para TG 135-499 mg/dL en alto riesgo."
      },
      "https://www.optimaldx.com/research-blog/lipid-biomarkers-very-low-density-lipoprotein-vldl": {
        "id": 17,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/research-blog/lipid-biomarkers-very-low-density-lipoprotein-vldl",
        "title": "Lipid Biomarkers: Very Low-Density Lipoprotein Cholesterol (VLDL-C)",
        "info": "Rangos VLDL-C: estándar 0-30 mg/dL, rango ODX óptimo 0-15 mg/dL. VLDL elevado asociado con aterosclerosis, eventos cardiovasculares, síndrome metabólico."
      },
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC7492406/": {
        "id": 18,
        "publisher": "PMC/NIH",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7492406/",
        "title": "The Association between Triglycerides and Incident Cardiovascular Disease",
        "info": "Estudio de 15,792 participantes: punto de inflexión riesgo TG ~150 mg/dL, hombres ~100 mg/dL, mujeres ~200 mg/dL. Promedio múltiples mediciones mejor predictivo que una sola."
      }
    },
    "Rangos de Medicina Funcional para Función Tiroidea": {
      "https://www.rupahealth.com/post/a-functional-medicine-approach-to-thyroid-hormone-labs": {
        "id": 19,
        "publisher": "Rupa Health",
        "url": "https://www.rupahealth.com/post/a-functional-medicine-approach-to-thyroid-hormone-labs",
        "title": "A Functional Medicine Approach to Thyroid Hormone Labs",
        "info": "Rangos óptimos de medicina funcional: TSH 0.5-2.5 mIU/L, T4 libre 1.0-1.5 ng/dL, T3 libre 3.0-4.0 pg/mL, T3 reverso <15 ng/dL, TPO <9 IU/mL, Tg <1 IU/mL. Protocolos de optimización con cofactores nutricionales."
      },
      "https://www.amymyersmd.com/blogs/articles/thyroid-test-results": {
        "id": 20,
        "publisher": "Amy Myers MD",
        "url": "https://www.amymyersmd.com/blogs/articles/thyroid-test-results",
        "title": "A Guide to Optimal Thyroid Levels From Tests",
        "info": "Rangos óptimos funcionales: TSH 1-2 µIU/mL, T4 libre >1.1 ng/dL, T3 libre >3.2 pg/mL, T3 reverso RT3:FT3 <10:1, TPO y Tg <4 IU/mL. Protocolos de optimización y explicación detallada de cada parámetro."
      },
      "https://www.ccfmed.com/blog/thyroid-health-isnt-just-tsh-a-functional-medicine-deep-dive": {
        "id": 21,
        "publisher": "California Center for Functional Medicine",
        "url": "https://www.ccfmed.com/blog/thyroid-health-isnt-just-tsh-a-functional-medicine-deep-dive",
        "title": "Thyroid Health Isn't Just TSH: A Functional Medicine Deep Dive",
        "info": "Rango óptimo TSH funcional 1.0-2.0 mIU/L vs 0.4-4.0 mIU/L convencional. Protocolo completo de medicina funcional para optimización tiroidea incluyendo análisis de causa raíz, nutrientes, salud intestinal y factores ambientales."
      },
      "http://www.ifm.org/articles/balancing-thyroid-hormones-naturally": {
        "id": 22,
        "publisher": "Institute for Functional Medicine (IFM)",
        "url": "http://www.ifm.org/articles/balancing-thyroid-hormones-naturally",
        "title": "Restoring Thyroid Hormone Balance",
        "info": "Enfoque integral de medicina funcional para balance tiroideo. Prevalencia hipotiroidismo 12% adultos. Estrategias de restauración hormonal incluyendo identificación de factores causales, nutrientes clave (yodo, hierro, selenio, zinc) y salud intestinal."
      },
      "https://advancedfunctionalmedicine.com.au/attaining-a-healthy-level-of-thyroid-autoimmune-antibodies/": {
        "id": 23,
        "publisher": "Advanced Functional Medicine Australia",
        "url": "https://advancedfunctionalmedicine.com.au/attaining-a-healthy-level-of-thyroid-autoimmune-antibodies/",
        "title": "Attaining a healthy level of thyroid autoimmune antibodies",
        "info": "Rangos óptimos para anticuerpos tiroideos: TPO <30 IU/mL, Anti-Tg <4 IU/mL, TSI <1.75 UI/L. Protocolos de reducción natural: vitamina D, selenio, melatonina, cambios dietéticos y manejo del estrés."
      },
      "https://drwillcole.com/normal-tsh-levels-your-guide/": {
        "id": 24,
        "publisher": "Dr. Will Cole",
        "url": "https://drwillcole.com/normal-tsh-levels-your-guide/",
        "title": "What Are Normal TSH Levels? Your Functional Medicine Guide",
        "info": "Rango TSH funcional 0.5-2.0 mIU/L vs convencional 0.4-4.0 mIU/L. Enfoque en identificación de causas raíz incluyendo autoinmunidad (90% casos), conversión T4-T3, resistencia tiroidea y factores contribuyentes."
      },
      "https://drchristinemaren.com/hashimotos-hypothyroidism/": {
        "id": 25,
        "publisher": "Dr. Christine Maren",
        "url": "https://drchristinemaren.com/hashimotos-hypothyroidism/",
        "title": "Hashimoto's Thyroiditis & Hypothyroidism",
        "info": "Rangos óptimos: TSH 1-2 mIU/L, T4 libre 1.1-1.4 ng/dL, T3 libre 3.2-3.8 pg/mL, T3 reverso <12 ng/dL, Anticuerpos negativos. Protocolo completo Hashimoto's incluyendo dieta, estilo de vida, suplementos y medicación."
      },
      "https://vitalitytulsa.com/functional-medicine-thyroid-levels/": {
        "id": 26,
        "publisher": "Vitality Functional Family Medicine",
        "url": "https://vitalitytulsa.com/functional-medicine-thyroid-levels/",
        "title": "Functional Medicine Thyroid Levels: Optimal Health Guide",
        "info": "Rango TSH funcional 1.0-2.0 mIU/L vs convencional 0.5-4.5. Estrategias de optimización incluyen manejo del estrés, ejercicio, sueño reparador, dieta antiinflamatoria y cofactores nutricionales (selenio, zinc, yodo)."
      },
      "https://www.nesaz.com/thyroid-testing/": {
        "id": 27,
        "publisher": "NESAZ",
        "url": "https://www.nesaz.com/thyroid-testing/",
        "title": "Thyroid Testing: 10 Key Labs & What They Mean",
        "info": "Comparación completa rangos: TSH funcional 0.5-2.0 vs convencional 0.4-4.0 mIU/L; T4 libre 1.0-1.5 vs 0.8-1.8 ng/dL; T3 libre 3.0-4.0 vs 2.3-4.2 pg/mL; T3 reverso 9-18 vs 8-25 ng/dL; TPO <15 vs <35 IU/mL; Tg <10 vs <20 IU/mL."
      },
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC10866328/": {
        "id": 28,
        "publisher": "PMC (Lancet Diabetes & Endocrinology)",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10866328/",
        "title": "The optimal healthy ranges of thyroid function defined by cardiovascular disease risk",
        "info": "Meta-análisis 134,346 participantes. Rangos óptimos basados en riesgo cardiovascular: FT4 percentiles 20-40, TSH percentiles 60-80 (mediana 1.90-2.90 mIU/L). Asociaciones no lineales con mortalidad y enfermedad cardiovascular."
      }
    },
    "Biomarcadores Nutricionales de Medicina Funcional": {
      "https://www.ifm.org/articles/vitamin-d-evaluation-personalized-medicine": {
        "id": 29,
        "publisher": "Institute for Functional Medicine (IFM)",
        "url": "https://www.ifm.org/articles/vitamin-d-evaluation-personalized-medicine",
        "title": "Vitamin D Evaluation: A Clinical Tool in Personalized Medicine",
        "info": "Rangos de vitamina D: deficiencia <20 ng/mL, suficiencia ≥30 ng/mL, nivel promedio en estudio VITAL 30.7 ng/mL considerado óptimo"
      },
      "https://www.knewhealth.com/understanding-your-lab-tests-vitamin-b12-and-rbc-folate": {
        "id": 30,
        "publisher": "Knew Health",
        "url": "https://www.knewhealth.com/understanding-your-lab-tests-vitamin-b12-and-rbc-folate",
        "title": "B12 & Folate Blood Tests: What Your Results Mean",
        "info": "Rangos óptimos funcionales: B12 800-1000 ng/L, folato RBC 1000-1500 ng/ml"
      },
      "https://www.optimaldx.com/research-blog/mineral-biomarkers-rbc-selenium": {
        "id": 31,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/research-blog/mineral-biomarkers-rbc-selenium",
        "title": "Mineral Biomarkers: RBC Selenium",
        "info": "Selenio RBC rango estándar 120-300 ug/L, rango ODX óptimo 135-255 ug/L"
      },
      "https://www.optimaldx.com/research-blog/biomarkers-of-inflammation-hs-crp": {
        "id": 32,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/research-blog/biomarkers-of-inflammation-hs-crp",
        "title": "Biomarkers of Inflammation: High-Sensitivity CRP",
        "info": "hs-CRP rango estándar 0.00-1.00 mg/L, rango ODX óptimo: hombres 0.00-0.55 mg/L, mujeres 0.00-1.00 mg/L"
      },
      "https://www.rupahealth.com/post/omega-3-fatty-acids-in-cardiovascular-health-a-functional-medicine-guide": {
        "id": 33,
        "publisher": "Rupa Health",
        "url": "https://www.rupahealth.com/post/omega-3-fatty-acids-in-cardiovascular-health-a-functional-medicine-guide",
        "title": "Omega-3 Fatty Acids in Cardiovascular Health: A Functional Medicine Guide",
        "info": "Omega-3 Index óptimo: >8% para reducir riesgo cardiovascular, EPA y DHA en membranas de glóbulos rojos"
      },
      "https://www.optimaldx.com/research-blog/biomarkers-of-iron-status-serum-iron": {
        "id": 34,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/research-blog/biomarkers-of-iron-status-serum-iron",
        "title": "Biomarkers of Iron Status: Serum Iron",
        "info": "Hierro sérico rango estándar 40-190 ug/dL, rango ODX óptimo 85-130 ug/dL"
      },
      "https://backontrack2wellness.com/iron-deficiency-anemia/": {
        "id": 35,
        "publisher": "Back on Track to Wellness",
        "url": "https://backontrack2wellness.com/iron-deficiency-anemia/",
        "title": "Iron-Deficiency Anemia - A Functional Medicine Approach",
        "info": "Ferritina óptima 50-100 ng/mL, saturación transferrina óptima >20%, deficiencia <30 ng/mL"
      },
      "https://drwillcole.com/longevity-101-your-complete-functional-medicine-guide-to-living-longer-healthier/": {
        "id": 36,
        "publisher": "Dr. Will Cole",
        "url": "https://drwillcole.com/longevity-101-your-complete-functional-medicine-guide-to-living-longer-healthier/",
        "title": "Longevity 101: Your Complete Functional Medicine Guide",
        "info": "Homocisteína óptima <7 µmol/L, CRP óptima <0.5 mg/L para longevidad"
      },
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC9650935/": {
        "id": 37,
        "publisher": "PMC (PubMed Central)",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9650935/",
        "title": "Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases",
        "info": "hs-CRP: bajo riesgo <1 mg/L, riesgo promedio 1-2 mg/L, alto riesgo >2 mg/L"
      }
    },
    "Investigación Rangos Funcionales Hepáticos y Renales": {
      "https://www.serenityhealthcarecenter.com/new-content/functional-vs-conventional-lab-testing-understanding-the-differences-for-optimal-health/": {
        "id": 38,
        "publisher": "Serenity Health Care Center",
        "url": "https://www.serenityhealthcarecenter.com/new-content/functional-vs-conventional-lab-testing-understanding-the-differences-for-optimal-health/",
        "title": "Functional vs. Conventional Lab Testing: Understanding the Differences for Optimal Health",
        "info": "Diferencias fundamentales entre rangos de referencia convencionales y rangos óptimos en medicina funcional, enfoque en detección temprana de disfunciones"
      },
      "https://www.drdaniel.com/articles/normal-blood-tests-not-the-same-as-optimal/": {
        "id": 39,
        "publisher": "Dr. Daniel",
        "url": "https://www.drdaniel.com/articles/normal-blood-tests-not-the-same-as-optimal/",
        "title": "Normal on Blood Tests Are Not the Same as Optimal",
        "info": "Explicación detallada de por qué los rangos normales no equivalen a rangos óptimos, bases conceptuales de medicina funcional"
      },
      "https://superpower.com/blog/optimal-liver-enzymes": {
        "id": 40,
        "publisher": "Superpower",
        "url": "https://superpower.com/blog/optimal-liver-enzymes",
        "title": "Evidence Based Optimal Ranges for AST & ALT",
        "info": "Rangos óptimos basados en evidencia para ALT (10-20 U/L) y AST (10-20 U/L) vs rangos convencionales más amplios"
      },
      "https://mindbodyfunctionalmedicine.com/blog/functional-medicine-lab-values-chart/": {
        "id": 41,
        "publisher": "Mind Body Functional Medicine",
        "url": "https://mindbodyfunctionalmedicine.com/blog/functional-medicine-lab-values-chart/",
        "title": "Functional Medicine Lab Values Chart",
        "info": "Tabla completa de valores funcionales incluyendo ALT (<26 mujeres, <30 hombres), AST (<26 mujeres, <30 hombres), BUN (13-18 mg/dL), creatinina (.65-.9 mujeres, .85-1.1 hombres)"
      },
      "https://www.rupahealth.com/post/understanding-the-important-of-testing-for-bun-and-creatinine-in-functional-medicine": {
        "id": 42,
        "publisher": "Rupa Health",
        "url": "https://www.rupahealth.com/post/understanding-the-important-of-testing-for-bun-and-creatinine-in-functional-medicine",
        "title": "Understanding The Importance of Testing for BUN and Creatinine In Functional Medicine",
        "info": "Importancia de BUN y creatinina en medicina funcional, factores de riesgo, interpretación funcional y enfoques de tratamiento integrativo"
      },
      "https://www.ultalabtests.com/blog/kidney/kidney-function-tests-early-detection-optimal-ranges/": {
        "id": 43,
        "publisher": "Ultra Lab Tests",
        "url": "https://www.ultalabtests.com/blog/kidney/kidney-function-tests-early-detection-optimal-ranges/",
        "title": "Kidney Function Tests – Early Detection & Optimal Ranges",
        "info": "Rangos funcionales óptimos para detección temprana de disfunción renal: creatinina (>0.90 mujeres, >1.10 hombres), eGFR (<90 mL/min/1.73 m²), BUN (>18 mg/dL)"
      },
      "https://www.rupahealth.com/post/interpreting-oxidative-stress-markers": {
        "id": 44,
        "publisher": "Rupa Health",
        "url": "https://www.rupahealth.com/post/interpreting-oxidative-stress-markers",
        "title": "Interpreting Oxidative Stress Markers",
        "info": "Marcadores de estrés oxidativo en medicina funcional: 8-OHdg, F2-isoprostanos, glutatión (GSH/GSSG), pruebas especializadas y estrategias de manejo"
      },
      "https://www.rupahealth.com/post/a-comprehensive-guide-to-nutrition-and-supplements-for-supporting-detoxification-pathways": {
        "id": 45,
        "publisher": "Rupa Health",
        "url": "https://www.rupahealth.com/post/a-comprehensive-guide-to-nutrition-and-supplements-for-supporting-detoxification-pathways",
        "title": "A Comprehensive Guide to Nutrition and Supplements for Supporting Detoxification Pathways",
        "info": "Protocolos de desintoxicación hepática: cardo mariano (200 mg 1-3x/día), NAC (600-1800 mg/día), cúrcuma (hasta 1500 mg/día), dieta mediterránea anti-inflamatoria"
      },
      "https://sac-nd.com/wp-content/uploads/2024/02/JaneSample-OptimalDX-Practitioner-Feb-03-2024.pdf": {
        "id": 46,
        "publisher": "Sacramento Naturopathic Medical Center",
        "url": "https://sac-nd.com/wp-content/uploads/2024/02/JaneSample-OptimalDX-Practitioner-Feb-03-2024.pdf",
        "title": "Functional Health Report - OptimalDX",
        "info": "Ejemplo de reporte funcional que demuestra análisis algorítmico de biomarcadores, interpretación funcional vs patológica, casos clínicos reales"
      },
      "https://www.hilarispublisher.com/open-access/liver-detox-protocols-evaluated-evidencebased-review-and-recommendations.pdf": {
        "id": 47,
        "publisher": "Hilaris Publisher",
        "url": "https://www.hilarispublisher.com/open-access/liver-detox-protocols-evaluated-evidencebased-review-and-recommendations.pdf",
        "title": "Liver Detox Protocols Evaluated: Evidence-based Review and Recommendations",
        "info": "Protocolos basados en evidencia para desintoxicación hepática: fibra soluble/insoluble, sulforafano (brócoli), cardo mariano, cúrcuma + piperina, evitar ayunos prolongados"
      },
      "https://www.kidney.org/sites/default/files/2024-08/ckd_evaluation_classification_stratification.pdf": {
        "id": 48,
        "publisher": "National Kidney Foundation",
        "url": "https://www.kidney.org/sites/default/files/2024-08/ckd_evaluation_classification_stratification.pdf",
        "title": "Clinical Practice Guidelines For Chronic Kidney Disease",
        "info": "Guías oficiales K/DOQI para evaluación renal: clasificación por etapas de enfermedad renal crónica, estimación de TFG, evaluación de proteinuria, criterios de laboratorio"
      }
    },
    "Rangos de Medicina Funcional para Biomarcadores Metabólicos": {
      "https://www.optimaldx.com/research-blog/fasting-insulin": {
        "id": 49,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/research-blog/fasting-insulin",
        "title": "Fasting Insulin - Biomarkers of Blood Glucose Regulation",
        "info": "Rangos estándar: 2-19 uIU/mL. Rangos óptimos: 2-5 uIU/mL según medicina funcional. Justificación clínica y puntos de corte para resistencia a la insulina."
      },
      "https://www.optimaldx.com/research-blog/biomarkers-of-blood-glucose-regulation-hba1c": {
        "id": 50,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/research-blog/biomarkers-of-blood-glucose-regulation-hba1c",
        "title": "HbA1C - Biomarkers of Blood Glucose Regulation",
        "info": "Rangos estándar: 0-5.7%. Rangos óptimos ODX: 4.6-5.3%. Incluye interpretación clínica, causas de elevación/falsificación, y meta para riesgo cardiovascular bajo."
      },
      "https://www.optimaldx.com/odx-blood-biomarker-guide": {
        "id": 51,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/odx-blood-biomarker-guide",
        "title": "The Complete ODX Biomarker Guide",
        "info": "Guía completa de rangos óptimos según medicina funcional para glucosa (75-86 mg/dL), HbA1c (4.6-5.3%), insulina (2-5 uIU/mL), péptido C (1.10-2.10 ng/mL), y HOMA-IR (0.75-1.25)."
      },
      "https://www.rupahealth.com/post/a-functional-medicine-protocol-for-balancing-blood-sugar": {
        "id": 52,
        "publisher": "Rupa Health",
        "url": "https://www.rupahealth.com/post/a-functional-medicine-protocol-for-balancing-blood-sugar",
        "title": "A Functional Medicine Protocol For Balancing Blood Sugar",
        "info": "Enfoque de medicina funcional para equilibrio glucémico. Rangos óptimos: insulina en ayunas <10 μU/mL, HOMA-IR <2.5, detección temprana de resistencia a la insulina."
      },
      "https://mybodytonic.com/how-to-interpret-labs-for-metabolic-health-a-functional-medicine-approach/": {
        "id": 53,
        "publisher": "My Body Tonic",
        "url": "https://mybodytonic.com/how-to-interpret-labs-for-metabolic-health-a-functional-medicine-approach/",
        "title": "Common Lab Values Explained: Functional Medicine Perspective",
        "info": "Rangos óptimos según medicina funcional: HbA1c 5-5.4%, glucosa en ayunas 70-85 mg/dL, insulina 2-5 mIU/L, HOMA-IR <2, triglicéridos <80 mg/dL, HDL 50-90 mg/dL."
      },
      "https://rootfunctionalmedicine.com/functional-medicine-insulin-resistance": {
        "id": 54,
        "publisher": "Root Functional Medicine",
        "url": "https://rootfunctionalmedicine.com/functional-medicine-insulin-resistance",
        "title": "Functional Medicine Insulin Resistance",
        "info": "Rangos óptimos de insulina en ayunas: 2-6 uIU/mL. Rangos normales convencionales: <18 uIU/mL. Glucosa óptima <90 mg/dL para evitar resistencia a la insulina."
      },
      "https://drhyman.com/blogs/content/blood-tests-to-ask-your-doctor-for": {
        "id": 55,
        "publisher": "Dr. Mark Hyman",
        "url": "https://drhyman.com/blogs/content/blood-tests-to-ask-your-doctor-for",
        "title": "Blood Tests to Ask your Doctor For",
        "info": "Rangos óptimos específicos: glucosa en ayunas <80 mg/dL, HbA1c <5.5%, insulina en ayunas 2-5 mIU/L, glucosa post-carga <110 mg/dL según medicina funcional avanzada."
      },
      "https://www.optimaldx.com/research-blog/biomarkers-cbc-hemoglobin": {
        "id": 56,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/research-blog/biomarkers-cbc-hemoglobin",
        "title": "CBC Biomarkers: Hemoglobin",
        "info": "Rangos óptimos de hemoglobina: hombres 14-15 g/dL, mujeres 13.5-14.5 g/dL según medicina funcional, superiores a rangos estándar convencionales."
      },
      "https://www.optimaldx.com/blog/quicki": {
        "id": 57,
        "publisher": "OptimalDX",
        "url": "https://www.optimaldx.com/blog/quicki",
        "title": "QUICKI - Insulin Sensitivity Index",
        "info": "Rango óptimo QUICKI: 0.35-0.45. Valores <0.30 indican probable diabetes. QUICKI es más preciso que HOMA-IR para evaluar resistencia a la insulina."
      },
      "https://www.atlantichealth.org/health-articles/healthy-living/5-signs-of-good-metabolic-health": {
        "id": 58,
        "publisher": "Atlantic Health System",
        "url": "https://www.atlantichealth.org/health-articles/healthy-living/5-signs-of-good-metabolic-health",
        "title": "5 Markers for Optimal Metabolic Health",
        "info": "Biomarcadores de salud metabólica óptima: glucosa <100 mg/dL, triglicéridos <150 mg/dL, HDL >50 (mujeres) >40 (hombres), enfoque integral metabólico especializado."
      }
    }
  }
}